Cellular Mol
The SELECT trial, published in 2023, additionally demonstrated that semaglutide reduces the risk of major cardiovascular events in adults with obesity and established cardiovascular disease suggesting cardiovascular benefit that extends beyond weight loss alone

Boss said that, because of the pattern they are noticing in their clinic, she feels patients should only have access to these drugs with clinical supervision, and that they should "undergo a psychological assessment first." Mixed Evidence and Ongoing Research Paul Kenny, director of the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai, New York, told Newsweek that he believed GLP-1s have "the potential to produce both positive and negative effects on mental well-being, depending on the individual, the dose, and the brain systems being engaged." He pointed to emerging research on the ability of these drugs to reduce craving and compulsive behaviors relating to food, nicotine, alcohol, and potentially other substances

Research published in the American Journal of Respiratory and Critical Care Medicine has found that people with asthma and chronic obstructive pulmonary disease (COPD) often show significantly lower glutathione levels in their airway fluid compared to healthy individuals
They are testing various aspects, such as: Efficacy : Researchers want to know how well semaglutide controls asthma symptoms compared to existing treatments